Nodify XL2
Blood-based proteomic classifier to identify lung nodules likely benign.
- Developer
- Biodesix
- Intended use
- Diagnostic Aid
- Cancer scope
- Not reported
- Specimen
- Serum
- Molecular modality
- Protein
- Current version
- Nodify XL2 current configuration (2026)
- Evidence context
- 1 structured studies · 0 indexed performance results · 1 sources
Why can reported performance numbers differ? MDI keeps each result attached to its study, population, stage or stratum, test version and source rather than treating performance as a fixed property of the test.